Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Drop Regimen Treating Pain and inflamMation Following Cataract Surgery Compared to SOC Topical Drop Regimen

NCT05626478 is registered in ClinicalTrials.gov with Nicole Fram M.D. as lead sponsor.

NCT NCT05626478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05626478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt in Conjunction With Topical Drop Regimen Treating Pain and inflamMation Following Cataract Surgery Compared to SOC Topical Drop Regimen
Lead sponsor
Nicole Fram M.D.
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2023
Completion date
February 5, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior chamber inflammation, cme - cystoid macular edema, corneal defect, corneal edema, corneal staining, ocular pain, visual outcome